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SINCE its introduction, peritoneal dialysis has been used more frequently in
Canada than in the United States, Europe or Japan. In Toronto, during 1979, 413
patients were maintained on dialysis in 5 teaching hospitals; of these, 232 (56
per cent) were on peritoneal dialysis. This figure reflects the superiority of
peritoneal dialysis as a home treatment - Wither as intermittent peritoneal
dialysis (IPD) or, recently, as continuous ambulatory peritoneal dialysis (CAPD),
over hemodialysis.
A recent study 1 of patients admitted to the continuous ambulatory peritoneal
dialysis program in Ontario during the last 2 years has demonstrated that
negative selection still operates among those admitted for chronic peritoneal
dialysis compared with those admitted for home hemodialysis. Thus CAPD is the
treatment of choice for diabetics, for those older than 55 or 60 years, for those
with hypertension and severe cardiovascular complications, and of course for
those who, for various reasons, are unable to continue on hemodialysis. For new
patients, an important factor in deciding the mode of dialysis is their preference,
especially if they belong to that group of patients who can be treated as effectively
with one form as the other.
This paper will present the clinical experience with patients on CAPD in the
Toronto Western Hospital program.
PATIENTS AND TECHNIQUES
Between September 1977 and June 1980, 115 patients (60 females and 55 males)
were admitted to our program. They ranged in age from 6 to 78 years, with an
average of 49.7. Their time on CAPD varied from I to 30 months (average 11.4
months). It is interesting to note that 7.8 per cent had polycystic kidneys and
8.7 per cent were diabetic.
All were dialyzed using the Toronto Western Hospital technique for CAPD 2.
The major modifications of the original technique were as follows: (1) The
connection tubing was changed every four weeks in hospital by the nurses
4instead of once a week by the patients at home; (2) the dressings were changed
every two days and in some patients once a week instead of once a day; (3) the
Luer end of the tubing was connected directly to the permanent catheter, to
prevent separation, and since January 1980 we have used the titanium connector
and tubing manufactured by Baxter Travenol Laboratories 3.
RESULTS AND DISCUSSION:
During their monthly visits the patients completed a questionnaire which was
subsequently analysed. Fifty-one per cent complained of tiredness at six months,
and the percentage increased to 69 at eighteen months. The mechanism under-
lying this complication is not clear; it may represent a combination of factors
such as depression, postural hypotension, anemia, chronic illness, etc. The
patients feel tired even though their biochemical and hematological control is as
good as, if not better than, that of those on hemodialysis or chronic intermittent
peritoneal dialysis. The possibility that this tiredness may be a manifestation of
a depletion syndrome should be explored in studies that would include a measure-
ment of trace metal concentration.
Between 26 per cent and 31 percent of these patients complained of mild to
moderate pruritus and 6 per cent to 11 per cent of severe pruritus. Many
patients suffered cramps, involving chiefly the legs and the abdominal muscles,
symptoms that probably reflect dehydration.
The table shows the biochemical control achieved with CAPD and the effect
that decreasing the dialysis volume from 8 to 6 litres a day has on the biochemical
values of 15 patients. The changes were significant only for BUN and serum
creatinine. Continuous ambulatory peritoneal dialysis is an excellent means of
controlling serum potassium, even with 6 litres of dialysate a day. CO2 levels
were maintained in a slightly acidotic range because the concentration of lactate
in the dialysate was relatively low, 35 mEq/1; perhaps the concentration should
be higher (40 mEq/l).
Continuous ambulatory peritoneal dialysis with small doses of antacids (2-4
g/day) provides satisfactory control of serum phosphorus. The control of serum
calcium is also satisfactory. However, a higher concentration of calcium may be
desirable, because we have observed that hyperparathyroidism persists in most
patients on CAPD when dialysed with a dialysate that has a calcium concen-
tration of 6 mg/dl.
During the first 3 months on CAPD the hemoglobin, hematocrit and red blood
cell count increase, but level off thereafter. It is interesting to note, however, that
there is a slight decline at the later stages for some reason that is not clear
(Figure I).
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Despite the removal of immunoglobulins by CAPD, the plasma immunoglobulin
levels remain within normal ranges.
Serum cholestrol concentration increased slightly, from an initial value of 205
mg/dl to around 280 mg/dl, but declined after the 18th month. Simitarly, serum
triglycerides initially are slightly increased, but increase further to between 400
and 500 mg/dl after 6 months on CAPD. As the high standard errors indicate, a
few patients have triglyceride levels about 1000 mg/dl. This hypertriglyceridemia,
which may predispose to accelerated atherosclerosis, may be related to the
continuous absorption of dextrose from the dialysate. If dextrose is indeed
responsible, we should consider the use of other osmotic agents, e.g. mixed amino-
acid solutions, as we suggested in the past '. The potential advantages of an
amino-acid-containing dialysate are the elimination of the side effects of dextrose,
and the enhancement of protein synthesis and improvement of hypoproteinemia.
Our experience with humans and with animals indicates that an amino-acid-
containing dialysate is as effective as a dextrose dialysate in producing ultra-
filtration and removing urea and creatinine.
CALCIUM AND BONE STATUS OF PATIENTS ON CAPD.
A dialysate with a calcium concentration of 6 mg% keeps the patient in a
negative peritoneal calcium balance ranging between 30 and 50 mg a day 3.
Radioligical investigations have shown that subperiosteal resorption continues in
most of them, and the hyperparathyroid bone disease persists or progresses in
these patients despite the good control of serum phosphorus. In contrast to
osteitis fibrosa, osteomalacia seems to respond to treatment with CAPD. Two
6of our patients who had osteomalacia, histologically confirmed, and multiple rib
fractures that did not respond to treatment with 1,25 dihydroxyvitamin D or DHT
achieved healing of their fractures while on CAPD.
Vascular calcifications do not progress in patients on CAPD, probably because
their calcium x phosphorus product is maintained within the normal range.
NUTRITIONAL STATUS OF PATIENTS ON CAPD
There is a gradual increase in mean body weight which probably reflects the
increase in appetite which develops after the institution of CAPD and the
absorption of dextrose. Nitrogen balance studies, done over short periods,
indicate that these patients are in a positive nitrogen balance 6, 7.
2
cu
a. 0
4-
Xu -
a.
0
(0
2IL
l~
O ;t 3 6 9 12 15 18 21 24 27 30
1977
Months After Institution of the TWH CAPD Programme
PERITONITIS AND OTHER COMPLICATIONS
Figure 2 shows the incidence of peritonitis in our unit expressed in episodes
per patient year for each quarter since we started CAPD in September 1977.
During the first 15 months, the infection rate remained grossly unchanged and
ranged between 1.3 and 1.5 episodes per patient per year. However, it has since
improved steadily and during the first quarter of 1980 declined to 0.41 episodes
per patient year or one episode every 28 patient months. The total experience (in
patient months) during each quarter is large enough to suggest that this is a real
trend. This improvement may be due to such factors as changing of the tubing
7by staff every month, the introduction of the Travenol Titanium adapter, and
the decrease in the number of exchanges. Whatever the reason(s), we seem to be
reaching the point where peritonitis will cease to be the major complication of
CAPD; for example, we have maintained 22 of our patients on CAPD for one
year and 3 of them for 2 years without a single episode of peritonitis.
MECHANICAL OR DIALYSIS-RELATED COMPLICATIONS
Catheter-tubing separations were encountered until we introduced the tech-
nique of connecting the Luer end of the tubing with the permanent catheter.
Recently, we adopted the Travenol Titanium Luer lock connector, which has
eliminated this problem. Skin exit site infection is still a serious problem and it
may require catheter replacement or may lead to peritonitis. Bloody effluent may
be related to menstruation. Early or late dialysate leak through the exit site may
be prevented by the introduction of the modified Toronto Western Hospital
catheter, which has a Dacron disc at the base of the peritoneal cuff to seal the
peritoneal hole. (Fig 3).
MEDICAL COMPLICATIONS OF CAPD
Although most of the cardiovascular complications were observed in our older
patients, it is still possible that these may be related to lipid abnormalities. They
included symptomatic hypotension (33), arrhythmia (8), pericarditis (5), myocardial
infarction (5), unstable angina (5) and reduced circulation to legs(4). Our research
into symptomatic hypotension suggests that in most of these patients it is related
to volume depletion ~.
Blood flow in the legs may decrease in patients who have obstructive lesions
in their femoral arteries. Our ultrasound studies of blood flow show that the
presence of 2 litres of dialysate leads to a further decrease in flow rate in patients
with a large-vessel lesion. In 2 such patients this complication lead to gangrene.
Whenever necessary, reconstructive vascular surgery should be carried out in
these circumstances.
Gastrointestinal complications are the most frequent, and are probably related
to the continuous presence in the abdomen of 2 litres of dialysate and the
8associated increase in the intra-abdominal pressure. They included nausea/ vomi-
ting (17), diarrhoea (15), deterioration of hiatus hernia (3), deterioration of
haemorroids (3), pancreatitis (1), hernias (11), colonic perforation (3), constipation
(very frequent).
Severe back pain, which occurred in 3 patients, is probably related to the
lordotic position imposed on these patients. This complication may become
serious in those with pre-existing lumbar disc disease.
OUTCOME OF CAPD
At the time of writing, of the 115 patients who entered our CAPD program,
60 are on CAPD and 26 have received a cadaveric kidney transplant after being
on CAPD for an average of 12 months. CAPD had to be interrupted in 20
patients and they were transferred to hemodialysis or to intermittent peritoneal
dialysis. Eleven patients died. The actuarial success rate for the first year was
57 per cent; the remaining 43 per cent represented those who were transferred
from CAPD to hemodialysis or intermittent peritoneal dialysis, and those who
died. The success rate for 2 years, 39 per cent, indicates that failures continue at
almost the same rate during the second year. Table V shows the reasons for
interruption of CAPD among the 20 patients transferred to intermittent peritoneal
dialysis or to hemodialysis. A significant number of the complications are clearly
preventable, suggesting that the success rate for CAPD can be improved in the
future.
TABLE-Comparison of the blood biochemical values on 3-bags and 4-bags days.
4 bag day
No. Mean Std Dev.
Blood urea nitrogen (mg%) 75
Serum determinations:
Creatinine (mg%) 77
Calcium (mg%) 77
Phosphorus (mg%) 77
Uric acid 77
Total protein 77
Albumin 69
Potassium 77
Cholesterol 22
Triglycerides 22
Mean blood pressure (lying) 76
Mean blood pressure (standing) 77
Body weight 75
Hemoglobin 78
Platelets (x 100/mm3) 33
3 bag day
No. Mean Std Dev. p
54.1 ± 16.6 75 68.7 + 19.18 .001
11.5 +
9.3 +
4.2 +
6.9 +
6.3 +
3.2 +
4.0 +
237.2 *
299.3 +
88.93 ±
83.8 -+-
67.8 -+-
9.3 +
501.3 +
1.5
0.64
0.75
1.03
0.93
0.44
0.59
80.7
134.2
15.2
18.9
14.92
1.9
106.41
75
75
75
75
75
68
75
27
27
75
75
75
75
34
12.8 +
9.2 +
4.8 +
7.2 +
6.4 +
3.4 +
4.2 +
217.9 +
273.5 +
94.1 +
92.4 +
69.3 +
8.9 +
438.76 +
1.4
0.57
0.84
0.83
0.5
0.49
0.58
51.4
133.7
19.6
17.5
13.59
2.2
106.5
.001
N.S.
.001
N.S.
N.S.
.01
N.S.
N.S.
N.S.
N.S.
.005
N.S.
N.S.
.05
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